{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:23:44Z","timestamp":1760243024718,"version":"build-2065373602"},"reference-count":41,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T00:00:00Z","timestamp":1432598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>In the interest of developing in vivo positron emission tomography (PET) probes for neuroimaging of calcium channels, we have prepared a carbon-11 isotopologue of a dihydropyridine Ca2+-channel antagonist, isradipine. Desmethyl isradipine (4-(benzo[c][1,2,5]oxadiazol-4-yl)-5-(isopropoxycarbonyl)-2,6-dimethyl-1,4-dihydropyridine -3-carboxylic acid) was reacted with [11C]CH3I in the presence of tetrabutylammonium hydroxide in DMF in an HPLC injector loop to produce the radiotracer in a good yield (6 \u00b1 3% uncorrected radiochemical yield) and high specific activity (143 \u00b1 90 GBq\u00b7\u00b5mol\u22121 at end-of-synthesis). PET imaging of normal rats revealed rapid brain uptake at baseline (0.37 \u00b1 0.08% ID\/cc (percent of injected dose per cubic centimeter) at peak, 15\u201360 s), which was followed by fast washout. After pretreatment with isradipine (2 mg\u00b7kg\u22121, i.p.), whole brain radioactivity uptake was diminished by 25%\u201340%. This preliminary study confirms that [11C]isradipine can be synthesized routinely for research studies and is brain penetrating. Further work on Ca2+-channel radiotracer development is planned.<\/jats:p>","DOI":"10.3390\/molecules20069550","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T11:07:05Z","timestamp":1432638425000},"page":"9550-9559","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist"],"prefix":"10.3390","volume":"20","author":[{"given":"Benjamin","family":"Rotstein","sequence":"first","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasily","family":"Belov","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"},{"name":"Department of Research, Shriners Hospitals for Children\u2014Boston, 51 Blossom Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Livni","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"},{"name":"Department of Research, Shriners Hospitals for Children\u2014Boston, 51 Blossom Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Bonab","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"},{"name":"Department of Research, Shriners Hospitals for Children\u2014Boston, 51 Blossom Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail","family":"Papisov","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"},{"name":"Department of Research, Shriners Hospitals for Children\u2014Boston, 51 Blossom Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Perlis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Center for Experimental Drugs and Diagnostics, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Vasdev","sequence":"additional","affiliation":[{"name":"Department of Radiology, Harvard Medical School, Division of Nuclear Medicine and Molecular Imaging and Center for Advanced Medical Imaging Sciences, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2015,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1124\/pr.57.4.5","article-title":"International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/chan.2.4.5847","article-title":"Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene-knockout models","volume":"2","author":"Striessnig","year":"2008","journal-title":"Channels"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/ng.209","article-title":"Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder","volume":"40","author":"Ferreira","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/ng.943","article-title":"Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4","volume":"43","author":"Sklar","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.1991.tb36487.x","article-title":"Synthetic Organic Ligands active at Voltage-Gated Calcium Channels","volume":"635","author":"Triggle","year":"1991","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1126\/science.2916127","article-title":"Nimodipine facilitates associative learning in aging rabbits","volume":"243","author":"Deyo","year":"1989","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1096\/fasebj.3.7.2565839","article-title":"Pharmacological basis for the use of nimodipine in central nervous system disorders","volume":"3","author":"Scriabine","year":"1989","journal-title":"FASEB J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0893-133X(94)00080-J","article-title":"Isradipine Suppresses Amphetamine-Induced Conditioned Place Preference and Locomotor Stimulation in the Rat","volume":"12","author":"Pucilowski","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nature05865","article-title":"\u201cRejuvenation\u201d protects neurons in mouse models of Parkinson\u2019s disease","volume":"447","author":"Chan","year":"2007","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.eplepsyres.2007.11.002","article-title":"Organic and inorganic calcium antagonists inhibit veratridine-induced epileptiform activity in CA3 neurons of the guinea pig","volume":"78","author":"Link","year":"2008","journal-title":"Epilepsy Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ajmg.b.30962","article-title":"Phenotypic effects of a bipolar liability gene among individuals with major depressive disorder","volume":"153B","author":"Casamassima","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/ajmg.b.31122","article-title":"L-type calcium channels and psychiatric disorders: A brief review","volume":"153B","author":"Casamassima","year":"2010","journal-title":"Am. J. Med. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ncomms2149","article-title":"CaV1.3-selective L-type calcium channel antagonists as potential new therapeutics for Parkinson\u2019s disease","volume":"3","author":"Kang","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e0117555","DOI":"10.1371\/journal.pone.0117555","article-title":"Preventing Effect of L-Type Calcium Channel Blockade on Electrophysiological Alterations in Dentate Gyrus Granule Cells Induced by Entorhinal Amyloid Pathology","volume":"10","author":"Pourbadie","year":"2015","journal-title":"PLoS ONE"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1093\/brain\/awu131","article-title":"CaV1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons","volume":"137","author":"Dragicevic","year":"2014","journal-title":"Brain"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/A:1023632419813","article-title":"1,4-Dihydropyridines as calcium channel ligands and privileged structures","volume":"23","author":"Triggle","year":"2003","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group (2013). Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson\u2019s disease (STEADY-PD). Mov. Disord., 28, 1823\u20131831.","DOI":"10.1002\/mds.25639"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/bdi.12143","article-title":"Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome-wide association","volume":"16","author":"Ostacher","year":"2014","journal-title":"Bipolar Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jlcr.3008","article-title":"PET radioligands targeting the brain GABAA\/benzodiazepine receptor complex","volume":"56","author":"Andersson","year":"2013","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/MNM.0000000000000032","article-title":"Neural nAChRs PET imaging probes","volume":"35","author":"Mo","year":"2014","journal-title":"Nucl. Med. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jlcr.3020","article-title":"Recent PET radioligands with optimal brain kinetics for imaging nicotinic acetylcholine receptors","volume":"56","author":"Horti","year":"2013","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/jlcr.2995","article-title":"Radiosynthesis of carbon-11 and fluorine-18 labelled radiotracers to image the ionotropic and metabotropic glutamate receptors: 11C and 18 F chemistry to image the glutamate receptors","volume":"56","author":"Sobrio","year":"2013","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0969-8051(97)00211-4","article-title":"Synthesis and Characterization of a 11C-Labelled Derivative of S12968: An Attempt to Image in Vivo Brain Calcium Channels","volume":"25","author":"Valette","year":"1998","journal-title":"Nucl. Med. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jlcr.2580270513","article-title":"Radiosynthesis of [11C]nifedipine and [11C]nicardipine","volume":"27","author":"Wilson","year":"1989","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/0883-2889(91)90227-R","article-title":"Synthesis of [isopropyl-11C]nimodipine for in vivo studies of dihydropyridine binding in man using positron emission tomography","volume":"42","author":"Roland","year":"1991","journal-title":"Int. J. Radiat. Appl. Instrum. Part A"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jlcr.2580290408","article-title":"Synthesis of carbon-11 labelled calcium channel antagonists","volume":"29","author":"Holschbach","year":"1991","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jlcr.1418","article-title":"1,4-Dihydropyridines (DHPs)-a class of very potent drugs: Syntheses of isotopically labeled DHP derivatives during the last four decades","volume":"50","author":"Pleiss","year":"2007","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1524\/ract.2008.1567","article-title":"Radiosynthesis of dimethyl-2-[18F]-(fluoromethyl)-6-methyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate for L-type calcium channel imaging","volume":"96","author":"Sadeghpour","year":"2008","journal-title":"Radiochim. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/0024-3205(94)00688-1","article-title":"Canine myocardial dihydropyridine binding sites: A positron emission tomographic study with the calcium channel inhibitor 11C-S11568","volume":"55","author":"Valette","year":"1994","journal-title":"Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0968-0896(97)00024-2","article-title":"Synthesis of two optically active calcium channel antagonists labelled with carbon-11 for in vivo cardiac PET imaging","volume":"5","author":"Hinnen","year":"1997","journal-title":"Bioorg. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jlcr.476","article-title":"Highly efficient synthesis of [11C]S12968 and [11C]S12967, for the in vivo imaging of the cardiac calcium channels using PET","volume":"44","author":"Valette","year":"2001","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_32","first-page":"932","article-title":"Myocardial Kinetics of the 11C-Labeled Enantiomers of the Ca2+ Channel Inhibitor S11568: An in Vivo Study","volume":"42","author":"Valette","year":"2001","journal-title":"J. Nucl. Med."},{"key":"ref_33","first-page":"1227","article-title":"In vivo quantification of myocardial dihydropyridine binding sites: A PET study in dogs","volume":"43","author":"Valette","year":"2002","journal-title":"J. Nucl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(25)23336-5","article-title":"Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes","volume":"239","author":"Maan","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/S0024-3205(97)00881-3","article-title":"Brain pharmacokinetics and in vivo receptor binding of 1,4-dihydropyridine calcium channel antagonists","volume":"61","author":"Uchida","year":"1997","journal-title":"Life Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0883-2889(90)90118-Z","article-title":"The use of [11C]diazomethane for labelling a calcium channel antagonist: PN 200-110 (isradipine)","volume":"41","author":"Crouzel","year":"1990","journal-title":"Int. J. Radiat. Appl. Instrum. Part A"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0969-8051(00)00132-3","article-title":"Radiotracer synthesis from [11C]-iodomethane: A remarkably simple captive solvent method","volume":"27","author":"Wilson","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/jlcr.1618","article-title":"Utility of commercial radiosynthetic modules in captive solvent [11C]-methylation reactions","volume":"52","author":"Wilson","year":"2009","journal-title":"J. Label. Compd. Radiopharm."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.mibio.2003.09.014","article-title":"Determination of lipophilicity and its use as a predictor of blood\u2013brain barrier penetration of molecular imaging agents","volume":"5","author":"Waterhouse","year":"2003","journal-title":"Mol. Imaging Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0022-2828(89)90861-4","article-title":"Interaction of 1,4 dihydropyridine calcium channel antagonists with biological membranes: Lipid bilayer partitioning could occur before drug binding to receptors","volume":"21","author":"Herbette","year":"1989","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0969-8043(00)00269-4","article-title":"An admonition when measuring the lipophilicity of radiotracers using counting techniques","volume":"54","author":"Wilson","year":"2001","journal-title":"Appl. Radiat. Isot."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/20\/6\/9550\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:46:54Z","timestamp":1760215614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/20\/6\/9550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,26]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6]]}},"alternative-id":["molecules20069550"],"URL":"https:\/\/doi.org\/10.3390\/molecules20069550","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2015,5,26]]}}}